OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
Trae Carroll, Sanjib Guha, Keith Nehrke, et al.
Biology (2021) Vol. 10, Iss. 10, pp. 1047-1047
Open Access | Times Cited: 24

Showing 24 citing articles:

The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 408

The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Haiqiong Ye, Yue Han, Ping Li, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 8, pp. 1557-1571
Closed Access | Times Cited: 44

Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1

Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders
Jong‐Min Suh, Mingeun Kim, Jeasang Yoo, et al.
Coordination Chemistry Reviews (2022) Vol. 478, pp. 214978-214978
Closed Access | Times Cited: 31

The Vascular-Immune Hypothesis of Alzheimer’s Disease
Rashi I. Mehta, Rupal I. Mehta
Biomedicines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 21

The common marmoset as a model of neurodegeneration
Claudia Pérez-Cruz, Juan D. Rodríguez-Callejas
Trends in Neurosciences (2023) Vol. 46, Iss. 5, pp. 394-409
Closed Access | Times Cited: 19

NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Yuri Zilberter, Dennis R. Tabuena, Misha Zilberter
Progress in Neurobiology (2023) Vol. 231, pp. 102539-102539
Open Access | Times Cited: 14

A Tau Pathogenesis-Based Network Pharmacology Approach for Exploring the Protections of Chuanxiong Rhizoma in Alzheimer’s Disease
Peng Zeng, Hong-Fei Su, Chao‐Yuan Ye, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22

Tau‐targeting nanoparticles for treatment of Alzheimer's disease
Shreya Pawar, Mohd Ahmar Rauf, Hosam Gharib Abdelhady, et al.
Exploration (2024)
Open Access | Times Cited: 4

Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Anna Maggiore, Valentina Latina, Maria D’Erme, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102578-102578
Open Access | Times Cited: 4

Distinct translatome changes in specific neural populations precede electroencephalographic changes in prion-infected mice
Lech Kaczmarczyk, Melvin Schleif, Lars Dittrich, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010747-e1010747
Open Access | Times Cited: 18

Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein
Juan S. Jiménez
Neuroscience (2022) Vol. 518, pp. 70-82
Closed Access | Times Cited: 17

Selective Vulnerability to Neurodegenerative Disease: Insights from Cell Type-Specific Translatome Studies
Walker S. Jackson, Susanne Bauer, Lech Kaczmarczyk, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 67-67
Open Access | Times Cited: 3

Pathogenic Oligomeric Tau alters Neuronal RNA Processes through the Formation of Nuclear Heteromeric Amyloids with RNA-Binding Protein Musashi1
Nicha Puangmalai, Abbigael E Aday, Madison Samples, et al.
Progress in Neurobiology (2025), pp. 102742-102742
Open Access

Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence
Paige Anton, Nicole Maphis, David N. Linsenbardt, et al.
Advances in experimental medicine and biology (2025), pp. 211-242
Closed Access

Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies
Ryder Davidson, Reese I. Krider, Philip Borsellino, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8816-8839
Open Access | Times Cited: 8

Tubulin Cytoskeleton in Neurodegenerative Diseases–not Only Primary Tubulinopathies
Zuzanna Cyske, Lidia Gaffke, Karolina Pierzynowska, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 5, pp. 1867-1884
Open Access | Times Cited: 10

Etiology matters: genetic and acquired prion diseases engage different mechanisms at a presymptomatic stage
Walker S. Jackson
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2707-2708
Open Access | Times Cited: 2

The γ-Adducin 1–357 fragment promotes tau pathology
Honglu Yu, Min Xiong, Congcong Liu, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2

Tau overload associated insufficient lysosomal hydrolysis activity through deacidification of lysosomes
Chao‐Yuan Ye, Peng Zeng, Yuan-Cheng Liu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top